Insider Transactions Reported by 10 Insiders of Inhibrx Biosciences, Inc.

Symbol
INBX on Nasdaq
Location
La Jolla, CA

Insiders trading volume in the past year

Inhibrx Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Mark P. Lappe Chief Executive Officer, Director $15,852,324 12 Sep 2024
Jon Faiz Kayyem Director $15,030,087 28 May 2025
Brendan P. Eckelman Chief Scientific Officer $6,127,372 29 May 2024
VIKING GLOBAL INVESTORS LP 10%+ Owner $3,317,364 -$11,287,500 -77% 07 Oct 2025
Douglas G. Forsyth Director $3,159,615 28 May 2025
Kristiina Vuori MD Director $306,645 28 May 2025
Kimberly Manhard Director $139,800 28 May 2025
Inhibrx, Inc. 10%+ Owner 29 May 2024
David Matly President 01 Apr 2025
Kelly Deck Chief Financial Officer 01 Apr 2025

Recent Insider Transactions by Companies or Individuals for Inhibrx Biosciences, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Viking Global Investors Lp INBX Common Stock Sale -83.9% $11,287,500 $32.25 -350,000 67,018 07 Oct 2025 See Explanation of Responses
Kimberly Manhard INBX Stock Option (right to buy) Award 15,000 15,000 28 May 2025 Direct
Kristiina Vuori MD INBX Stock Option (right to buy) Award 15,000 15,000 28 May 2025 Direct
Jon Faiz Kayyem INBX Stock Option (right to buy) Award 15,000 15,000 28 May 2025 Direct
Douglas G. Forsyth INBX Stock Option (right to buy) Award 15,000 15,000 28 May 2025 Direct
Kelly Deck INBX Stock Option (right to buy) Award 15,000 15,000 01 Apr 2025 Direct
David Matly INBX Stock Option (right to buy) Award 50,000 50,000 01 Apr 2025 Direct
Jon Faiz Kayyem INBX Common Stock Gift -17.7% -90,000 419,360 27 Mar 2025 By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.